WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

EFFICACY OF SHADBINDU TAILA AND AGASTYA HARITAKI IN CHRONIC SINUSITIS

Tipu*, Anuradha Bhasin and Adish

.

Abstract

The Disease of Head (Headache) are caused by individual Doshas i.e. Aggravated Vata, Pitta and Kapha or By Simultaneous vitiation of all three Doshas together (Sannipataja) Among the Different types of shiroroga mentioned in Samhitas, Suryavarta is the One of the Common Disease in Day to Day life. The Symptoms of Suryavarta almost Resemble to Frontal Sinusitis. Sinusitis is a very Common Chronic illness with a Substantial Health Care impact. According to National Institute of Allergy and infectious Diseases (NIAID) An estimated 134 million Indians suffer from chronic Sinusitis. Among Indians, This Disease is more Widespread than Diabetes, Asthma or Coronary heart Disease. One in eight Indians suffer from chronic Sinusitis caused By the inflammation of the Nasal & Throat lining, which result in the Accumulation of mucus in the Sinus Cavity and Pressure Build-up in the face, eye and Brain. In this Clinical Rescarch Study, we will study the effect of 30 Patients suffering from Chronic Sinusitis were enrolled in Clinical Study to asses the efficacy of Shadbindu Taila and Agastaya Haritaki. The Dose of Agastya Haritaki is 10gm/day Divided in Two doses, Nasya of Shadbindu Taila 4 Drops each Nostrils was given. The duration of the Treatment is 2 months and follow upwas done for 3months. Radiological investigation was done periodically. The Patients examined Clinically in every week to asses the effect of Medicine. In the Present study Results obtained with Respect to all the Parameters were all Satistically. Out of 30 Patient 25 (83%) got Marked Relief and 5 (16%) got moderate Relief from the parameters Considered for the study. Even after Follow-up there was no recurrence. Hence this treatment could be Recommended for treatment of Chronic Sinusitis.

Keywords: Sinus, Suryavarta, Shiroroga Frontal Sinusitis, Nasya, Shadbindu Taila, Agastya Haritaki.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More